EdgarLookup
SC 13G

SC 13G Filing

Company
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
Filed
April 26, 2017
Accession Number
0001493152-17-004420

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →